skip to main content

    Updated Visitor Guidelines

 

MENU

 

Adrenal Tumors/Cancer

Using science and faith to live with adrenal cancer

Adrenal cancer is diagnosed in one in every million people — and studies to test new treatments for it are just as rare. As the first patient in one of the few clinical trials for the disease, Tina Reuben hopes her participation will advance the field.

Treatment Targets Tough Cancers by Bathing Tumors in Chemo

The biggest threat cancer poses happens when it spreads throughout the body -- and when it has spread to the lining of the abdominal cavity it's particularly tricky. Once these advanced cancers have entered that area, they’re notoriously difficult to treat. Surgery alone is rarely successful, and traditional chemotherapy yields limited results, but a treatment called HIPEC offers hope.

Michigan Medicine and the American Australian Asian Adrenal Alliance: International Collaboration to Study Adrenal Disorders

U-M is a leader in benign adrenal disorders which include primary aldosteronism (discovered by U-M endocrinologist Jerome Conn), hypercortisolism, and pheochromocytoma/paraganglioma (excess production of adrenaline). For many years, there has been a desire to bring together a large network of institutions to work collaboratively to study adrenal disorders in a manner unable to be accomplished by single institutions or by using existing large national databases.

Pages